Condition

Lung Diseases, Interstitial clinical trials and research

• 12Clinical trials
• 24Countries

Newest Lung Diseases, Interstitial clinical trials

All recruiting trials (12)

• TX000045 for pulmonary hypertension from interstitial lung disease

  This study tests TX000045 to see if it can reduce pulmonary vascular resistance in people with PH caused by interstitial lung disease and to check its safety.

  Recruiting at 12 sites Phase 2 Tectonic Operating Company, Inc. · Phoenix, Arizona and 15 other locations · NCT07473700

• Nebulized human amniotic fluid for interstitial lung disease

  This pilot will try nebulized diluted human amniotic fluid (HAF‑Matrix) in adults 40–90 with interstitial lung disease to check safety and look for early signs of benefit.

  Recruiting Phase 1 Maule Stem Cell Research Institute, Inc. · Venice, Florida · NCT07372989

• Evaluating Belimumab for Lung Disease Linked to Autoimmune Conditions

  This study is testing if the medication belimumab can help adults with lung disease caused by autoimmune conditions feel better and breathe easier.

  Recruiting at 126 sites Phase 3 GlaxoSmithKline · Los Angeles, California and 131 other locations · NCT06572384

• Evaluating Olokizumab for Progressive Fibrosing Lung Diseases

  This study is testing if a new injection called olokizumab can help people with progressive fibrosing lung diseases breathe better and improve their overall health compared to a placebo.

  Recruiting at 33 sites Phase 2/3 R-Pharm · Barnaul and 32 other locations · NCT06440746

• Testing hymecromone in adults with interstitial lung disease

  This study is testing a new medication called hymecromone to see if it can help adults with progressive interstitial lung disease feel better and improve their lung function.

  Recruiting Phase 2 National Institutes of Health Clinical Center (CC) · Research Triangle Park, North Carolina · NCT06325696

• Digital self-management package for people with interstitial lung disease

  This study is testing a new smartphone app designed to help people with interstitial lung disease manage their health better and feel improved overall compared to standard care.

  Recruiting at 4 sites University of Sydney · Sydney, New South Wales and 3 other locations · NCT06122233

• Using cough samples to analyze lung health

  This study is testing whether cough samples can help us find signs of lung diseases by comparing them to samples taken from healthy people and smokers.

  Recruiting Albert Einstein College of Medicine · The Bronx, New York · NCT05854563

• CTD-related interstitial lung disease in Mexico: patterns, treatments, and outcomes

  This project will collect health data to see how interstitial lung disease linked to connective tissue diseases affects adults in Mexico and how other illnesses and treatments relate to progression, flare-ups, or death.

  Recruiting Boehringer Ingelheim · Mexico City · NCT05819385

• Creating a database for patients at risk of interstitial lung disease

  This study is trying to create a database to help track and monitor patients at risk for interstitial lung disease so they can catch it early and manage it better.

  Recruiting Medical University of Graz · Graz · NCT04707781

• Comparing home-based and hospital-based pulmonary rehabilitation for bronchiectasis

  This study is testing whether doing pulmonary rehabilitation at home or in the hospital is better for people with bronchiectasis to see which helps them breathe easier and feel better.

  Recruiting Istanbul Medipol University Hospital · Istanbul, Zeytinburnu · NCT03561818

• European database and biobank for childhood interstitial lung diseases

  This study is creating a database and biobank to collect information and samples from children with interstitial lung diseases across Europe to improve their treatment and understanding of these conditions.

  Recruiting at 3 sites Ludwig-Maximilians - University of Munich · Hanover, Lower Saxony and 2 other locations · NCT02852928

• Registry for interstitial lung disease patients

  This study is gathering medical records from people with interstitial lung disease to help researchers learn more about the condition and improve future treatments.

  Recruiting University of Pittsburgh · Pittsburgh, Pennsylvania · NCT00258583

Related topics

Quick answers

How many Lung Diseases, Interstitial clinical trials are recruiting right now?

12, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 24 countries. The most sites are in United States (6 trials), Mexico (2 trials), Australia (2 trials), Germany (2 trials), South Korea (2 trials). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 2, Phase 1: 1, Phase 2/3: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →